![Sung-Yeon Im](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sung-Yeon Im
Directeur/Bestuurslid bij HANALL BIOPHARMA CO., LTD.
Profiel
Sung-Yeon Im is currently the Director & Managing Director at HANALL BIOPHARMA Co., Ltd., Director at Daewoong Development Co., Ltd., and Auditor at Daewoong Bio, Inc. and Daewoong Management Development Institute.
Previously, Mr. Im was an Executive Board Member & Head-Accounting at Daewoong Co., Ltd.
Mr. Im received an undergraduate degree from Hong-Ik University and a graduate degree from Korea Advanced Institute of Science & Technology.
Actieve functies van Sung-Yeon Im
Bedrijven | Functie | Begin |
---|---|---|
HANALL BIOPHARMA CO., LTD. | Directeur/Bestuurslid | 22-03-2019 |
Daewoong Development Co., Ltd.
![]() Daewoong Development Co., Ltd. Real Estate DevelopmentFinance Part of Daewoong Co., Ltd., Daewoong Development Co., Ltd. is a pharmaceutical company based in Seoul, South Korea. The South Korean company focuses on creating better value for the healthy life of its customers through ceaseless research and development. Daewoong Development Co. provides a comfortable work space where employees can work flexibly and happily. The company also supports education on the local language and culture to help employees grow into talents. The CEO of the company is Jae-Chun Yoon. | Directeur/Bestuurslid | - |
Daewoong Bio, Inc.
![]() Daewoong Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Daewoong Bio, Inc. provides pharmaceutical raw materials and intermediate products. Its products include acids, anti-hyperlipidaemic agents, tranquilisers, antiulcerants, antifungals, dietary supplements, anti-thrombotics, cephalosporins, anti-hypertensives, hepatic protectors, penicillin, digestives, diphenyl dimethyl bicarboxylate, amoxicillin, and alibendol. The company was founded on April 15, 1983 and is headquartered in Hwaseong, South Korea. | Comptroller/Controller/Auditor | - |
Daewoong Management Development Institute | Comptroller/Controller/Auditor | - |
Eerdere bekende functies van Sung-Yeon Im
Bedrijven | Functie | Einde |
---|---|---|
DAEWOONG CO., LTD. | Comptroller/Controller/Auditor | - |
Opleiding van Sung-Yeon Im
Hong-Ik University | Undergraduate Degree |
Korea Advanced Institute of Science & Technology | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
DAEWOONG CO., LTD. | Health Technology |
HANALL BIOPHARMA CO., LTD. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Daewoong Development Co., Ltd.
![]() Daewoong Development Co., Ltd. Real Estate DevelopmentFinance Part of Daewoong Co., Ltd., Daewoong Development Co., Ltd. is a pharmaceutical company based in Seoul, South Korea. The South Korean company focuses on creating better value for the healthy life of its customers through ceaseless research and development. Daewoong Development Co. provides a comfortable work space where employees can work flexibly and happily. The company also supports education on the local language and culture to help employees grow into talents. The CEO of the company is Jae-Chun Yoon. | Finance |
Daewoong Bio, Inc.
![]() Daewoong Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Daewoong Bio, Inc. provides pharmaceutical raw materials and intermediate products. Its products include acids, anti-hyperlipidaemic agents, tranquilisers, antiulcerants, antifungals, dietary supplements, anti-thrombotics, cephalosporins, anti-hypertensives, hepatic protectors, penicillin, digestives, diphenyl dimethyl bicarboxylate, amoxicillin, and alibendol. The company was founded on April 15, 1983 and is headquartered in Hwaseong, South Korea. | Commercial Services |
Daewoong Management Development Institute |